top of page

Repairing the brain with stem cells

2013/04/30

 

Anchor 20

The first clinical trial of stem cells for a neurodegenerative disease in the UK is now underway. Does this mean that a new era of regenerative medicine for brain disorders is upon us? Could it also herald the advent of 'human enhancement' using stem cell technologies? Or is it possible that neuroscientists don't really know what they are doing, and just got lucky?

 

Jack Price is Professor of Developmental Neurobiology at the Institute of Psychiatry, King's College London, and is Head of the Institute's Centre for the Cellular Basis of Behaviour. He is also a consultant for ReNeuron Ltd., a UK biotech company, developing stem cells for therapeutic and drug discovery applications. Jack Price has worked on neural stem cells in various guises for about twenty-five years, and has more recently being pursuing an interest in modelling neurodevelopmental disorders using stem cells.

 

bottom of page